Advertisement

Journal of Molecular Neuroscience

, Volume 51, Issue 3, pp 779–787 | Cite as

Ceftriaxone Treatment Affects the Levels of GLT1 and ENT1 As Well As Ethanol Intake in Alcohol-Preferring Rats

  • Youssef SariEmail author
  • Sai N. Sreemantula
  • Moonnoh R. Lee
  • Doo-Sup Choi
Article

Abstract

Studies have demonstrated that deletion of equilibrative nucleoside transporter 1 (ENT1) is associated with reduced glutamate transporter 1 (GLT1) level, and consequently increased ethanol intake. In this study, we measured changes in GLT1 and ENT1 levels in prefrontal cortex (PFC), and nucleus accumbens (NAc) core and shell associated with alcohol drinking in alcohol-preferring (P) rats. We examined, then, whether ceftriaxone (CEF) would affect both GLT1 and ENT1 levels in these brain regions. P rats were given 24-h concurrent access to 15 and 30 % ethanol, water, and food for 5 weeks. On Week 6, P rats received 100 mg/kg CEF (i.p.) or a saline vehicle for five consecutive days. Ethanol intake was measured daily for 8 days starting on the first day of injections. We found a significant reduction in daily ethanol intake in CEF-treated group, starting on Day 2 of injections. Western blot for GLT1 and binding assay for ENT1 revealed downregulation of GLT1 level, whereas ENT1 levels were increased in the NAc core and NAc shell, respectively, but not in the PFC in saline vehicle group. Importantly, CEF treatment reversed these effects in both NAc core and shell. These findings provide evidence for potential regulatory effects of CEF on both GLT1 and ENT1 expression in reducing ethanol intake.

Keywords

ENT1 GLT1 EAAT2 Alcohol dependence Glutamate 

Notes

Acknowledgments

This work was supported by Award Number R01AA019458 (Y.S.) and R01AA018779 (D-S. C.) from the National Institutes on Alcohol Abuse and Alcoholism. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute on Alcohol Abuse and Alcoholism or the National Institutes of Health. The authors would like to thank Mrs. Charisse Montgomery for editing this manuscript.

Conflict of interest

The authors declare no conflict of interest.

References

  1. Berridge KC, Robinson TE (1998) What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience? Brain Res Brain Res Rev 28:309–369PubMedCrossRefGoogle Scholar
  2. Childress AR, Mozley PD, McElgin W, Fitzgerald J, Reivich M, O'Brien CP (1999) Limbic activation during cue-induced cocaine craving. Am J Psychiatry 156:11–18PubMedGoogle Scholar
  3. Choi DS, Cascini MG, Mailliard W, Young H, Paredes P, McMahon T, Diamond I, Bonci A, Messing RO (2004) The type 1 equilibrative nucleoside transporter regulates ethanol intoxication and preference. Nat Neurosci 7:855–861PubMedCrossRefGoogle Scholar
  4. Danbolt NC (2001) Glutamate uptake. Prog Neurobiol 65:1–105PubMedCrossRefGoogle Scholar
  5. Ginsberg SD, Martin LJ, Rothstein JD (1995) Regional deafferentation down-regulates subtypes of glutamate transporter proteins. J Neurochem 65:2800–2803PubMedCrossRefGoogle Scholar
  6. Goldstein RZ, Volkow ND (2002) Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex. Am J Psychiatry 159:1642–1652PubMedCrossRefGoogle Scholar
  7. Harvey J, Lacey MG (1997) A postsynaptic interaction between dopamine D1 and NMDA receptors promotes presynaptic inhibition in the rat nucleus accumbens via adenosine release. J Neurosci 17:5271–5280PubMedGoogle Scholar
  8. Kalivas PW (2004) Glutamate systems in cocaine addiction. Curr Opin Pharmacol 4:23–29PubMedCrossRefGoogle Scholar
  9. Kim K, Lee SG, Kegelman TP, Su ZZ, Das SK, Dash R, Dasgupta S, Barral PM, Hedvat M, Diaz P, Reed JC, Stebbins JL, Pellecchia M, Sarkar D, Fisher PB (2011) Role of excitatory amino acid transporter-2 (EAAT2) and glutamate in neurodegeneration: opportunities for developing novel therapeutics. J Cell Physiol 226:2484–2493PubMedCrossRefGoogle Scholar
  10. Knackstedt LA, Melendez RI, Kalivas PW (2010) Ceftriaxone restores glutamate homeostasis and prevents relapse to cocaine seeking. Biol Psychiatry 67:81–84PubMedCrossRefGoogle Scholar
  11. Krystal JH, Petrakis IL, Mason G, Trevisan L, D'Souza DC (2003) N-Methyl-d-aspartate glutamate receptors and alcoholism: reward, dependence, treatment, and vulnerability. Pharmacol Ther 99:79–94PubMedCrossRefGoogle Scholar
  12. Melendez RI, Hicks MP, Cagle SS, Kalivas PW (2005) Ethanol exposure decreases glutamate uptake in the nucleus accumbens. Alcohol Clin Exp Res 29:326–333PubMedCrossRefGoogle Scholar
  13. Miller BR, Dorner JL, Shou M, Sari Y, Barton SJ, Sengelaub DR, Kennedy RT, Rebec GV (2008) Up-regulation of GLT1 expression increases glutamate uptake and attenuates the Huntington's disease phenotype in the R6/2 mouse. Neuroscience 153:329–337PubMedCrossRefGoogle Scholar
  14. Mitani A, Tanaka K (2003) Functional changes of glial glutamate transporter GLT-1 during ischemia: an in vivo study in the hippocampal CA1 of normal mice and mutant mice lacking GLT-1. J Neurosci 23:7176–7182PubMedGoogle Scholar
  15. Nam HW, Lee MR, Zhu Y, Wu J, Hinton DJ, Choi S, Kim T, Hammack N, Yin JC, Choi DS (2011) Type 1 equilibrative nucleoside transporter regulates ethanol drinking through accumbal N-methyl-d-aspartate receptor signaling. Biol Psychiatry 69:1043–1051PubMedCrossRefGoogle Scholar
  16. Nam HW, McIver SR, Hinton DJ, Thakkar MM, Sari Y, Parkinson FE, Haydon PG, Choi DS (2012) Adenosine and glutamate signaling in neuron–glial interactions: implications in alcoholism and sleep disorders. Alcohol Clin Exp Res 36:1117–1125PubMedCrossRefGoogle Scholar
  17. Othman T, Sinclair CJ, Haughey N, Geiger JD, Parkinson FE (2002) Ethanol alters glutamate but not adenosine uptake in rat astrocytes: evidence for protein kinase C involvement. Neurochem Res 27:289–296PubMedCrossRefGoogle Scholar
  18. Parkinson FE, Xiong W, Zamzow CR, Chestley T, Mizuno T, Duckworth ML (2009) Transgenic expression of human equilibrative nucleoside transporter 1 in mouse neurons. J Neurochem 109:562–572PubMedCrossRefGoogle Scholar
  19. Paxinos G, Watson C (2007) The rat brain in stereotaxic coordinates, 6th edn. Academic, New YorkGoogle Scholar
  20. Qrunfleh AM, Alazizi A, Sari Y (2013) Ceftriaxone, a beta-lactam antibiotic, attenuates relapse-like ethanol-drinking behavior in alcohol-preferring rats. J Psychopharmacol 27:541–549PubMedCrossRefGoogle Scholar
  21. Rothstein JD (1995) Excitotoxicity and neurodegeneration in amyotrophic lateral sclerosis. Clin Neurosci 3:348–359PubMedGoogle Scholar
  22. Rothstein JD, Patel S, Regan MR, Haenggeli C, Huang YH, Bergles DE, Jin L, Dykes Hoberg M, Vidensky S, Chung DS, Toan SV, Bruijn LI, Su ZZ, Gupta P, Fisher PB (2005) Beta-lactam antibiotics offer neuroprotection by increasing glutamate transporter expression. Nature 433:73–77PubMedCrossRefGoogle Scholar
  23. Rothstein JD, Van Kammen M, Levey AI, Martin LJ, Kuncl RW (1995) Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis. Ann Neurol 38:73–84PubMedCrossRefGoogle Scholar
  24. Sari Y, Franklin KM, Alazizi A, Rao PS, Bell RL (2013) Effects of ceftriaxone on the acquisition and maintenance of ethanol drinking in peri-adolescent and adult female alcohol-preferring (P) rats. Neuroscience 241:229–238PubMedCrossRefGoogle Scholar
  25. Sari Y, Prieto AL, Barton SJ, Miller BR, Rebec GV (2010) Ceftriaxone-induced up-regulation of cortical and striatal GLT1 in the R6/2 model of Huntington's disease. J Biomed Sci 17:62PubMedCrossRefGoogle Scholar
  26. Sari Y, Sakai M, Weedman JM, Rebec GV, Bell RL (2011) Ceftriaxone, a beta-lactam antibiotic, reduces ethanol consumption in alcohol-preferring rats. Alcohol Alcohol 46:239–246PubMedCrossRefGoogle Scholar
  27. Sari Y, Smith KD, Ali PK, Rebec GV (2009) Upregulation of GLT1 attenuates cue-induced reinstatement of cocaine-seeking behavior in rats. J Neurosci 29:9239–9243PubMedCrossRefGoogle Scholar
  28. Sari Y, Sreemantula SN (2012) Neuroimmunophilin GPI-1046 reduces ethanol consumption in part through activation of GLT1 in alcohol-preferring rats. Neuroscience 227C:327–335CrossRefGoogle Scholar
  29. Schreiber R, Freund WD (2000) Glutamate transport is downregulated in the cerebral cortex of alcohol-preferring rats. Med Sci Monit 6:649–652PubMedGoogle Scholar
  30. Smith AD, Weiss F (1999) Ethanol exposure differentially alters central monoamine neurotransmission in alcohol-preferring versus -nonpreferring rats. J Pharmacol Exp Ther 288:1223–1228PubMedGoogle Scholar
  31. Smith TL (1997) Regulation of glutamate uptake in astrocytes continuously exposed to ethanol. Life Sci 61:2499–2505PubMedCrossRefGoogle Scholar
  32. Wu J, Lee MR, Choi S, Kim T, Choi DS (2010) ENT1 regulates ethanol-sensitive EAAT2 expression and function in astrocytes. Alcohol Clin Exp Res 34:1110–1117PubMedCrossRefGoogle Scholar
  33. Wu J, Lee MR, Kim T, Johng S, Rohrback S, Kang N, Choi DS (2011) Regulation of ethanol-sensitive EAAT2 expression through adenosine A1 receptor in astrocytes. Biochem Biophys Res Commun 406:47–52PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  • Youssef Sari
    • 1
    Email author
  • Sai N. Sreemantula
    • 1
  • Moonnoh R. Lee
    • 2
  • Doo-Sup Choi
    • 2
  1. 1.Department of Pharmacology, College of Pharmacy and Pharmaceutical SciencesUniversity of ToledoToledoUSA
  2. 2.Department of Molecular Pharmacology and Experimental TherapeuticsMayo Clinic College of MedicineRochesterUSA

Personalised recommendations